PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California, USA.\', \'Hematologic Malignancies Research Institute, City of Hope National Medical Center, Duarte, California, USA.\', \'Pathogen and Microbiome Institute, Northern Arizona Universitygrid.261120.6, Flagstaff, Arizona, USA.\', \'Disease Intervention and Prevention, and Population Health Programs, Texas Biomedical Research Institutegrid.250889.e, San Antonio, Texas, USA.\', \'Department of Computational and Quantitative Medicine, City of Hope National Medical Center, Duarte, California, USA.\', \'Pathology Core, Shared Resources, Beckman Research Institute, City of Hope National Medical Center, Duarte, California, USA.\', \'Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.\', \'Department of Pathology, The Ohio State University, Columbus, Ohio, USA.\', \'City of Hope Comprehensive Cancer Center, Duarte, California, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1128/JVI.00964-21
?:doi
?:hasPublicationType
?:journal
  • Journal of virology
is ?:pmid of
?:pmid
?:pmid
  • 34668775
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.853
?:rankingScore_hIndex
  • 268
is ?:relation_isRelatedTo_publication of
?:title
  • The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all